Cargando…

Multiple primary melanomas: Our experience

Patients with melanoma have an increased risk of having other neoplasms, and particularly other melanomas and non-melanoma skin cancers. The study aimed to describe multiple primary melanomas in a large medical university centre from Romania (Cluj-Napoca) from 2004 to 2020. Out of 699 patients with...

Descripción completa

Detalles Bibliográficos
Autores principales: Ungureanu, Loredana, Zboraș, Iulia, Vasilovici, Alina, Vesa, Ștefan, Cosgarea, Ioana, Cosgarea, Rodica, Șenilă, Simona
Formato: Online Artículo Texto
Lenguaje:English
Publicado: D.A. Spandidos 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725020/
https://www.ncbi.nlm.nih.gov/pubmed/33363599
http://dx.doi.org/10.3892/etm.2020.9520
_version_ 1783620628040908800
author Ungureanu, Loredana
Zboraș, Iulia
Vasilovici, Alina
Vesa, Ștefan
Cosgarea, Ioana
Cosgarea, Rodica
Șenilă, Simona
author_facet Ungureanu, Loredana
Zboraș, Iulia
Vasilovici, Alina
Vesa, Ștefan
Cosgarea, Ioana
Cosgarea, Rodica
Șenilă, Simona
author_sort Ungureanu, Loredana
collection PubMed
description Patients with melanoma have an increased risk of having other neoplasms, and particularly other melanomas and non-melanoma skin cancers. The study aimed to describe multiple primary melanomas in a large medical university centre from Romania (Cluj-Napoca) from 2004 to 2020. Out of 699 patients with melanoma included in the study, 26 (3.71%) developed multiple tumours. The 26 patients developed a total of 59 melanomas, corresponding to a mean of 2.3 melanomas per patient. The site and histological subtype of the first and second melanomas were not consistent. The proportion of subsequent melanomas that were in situ (51.5%) or thin melanomas (<1 mm, 24.2%) was higher compared with first melanomas (7.7%, respectively 11.5%). The median and mean time to diagnosis was 2.75 months, respectively, 28.09 months. In total, 76.92% of second melanomas were detected within three years, but we were able to document a subsequent melanoma more than ten years after the first diagnosis. The study highlights the importance of follow-up in patients diagnosed with melanoma, not only in the first years after the primary diagnoses but for the entire life.
format Online
Article
Text
id pubmed-7725020
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher D.A. Spandidos
record_format MEDLINE/PubMed
spelling pubmed-77250202020-12-23 Multiple primary melanomas: Our experience Ungureanu, Loredana Zboraș, Iulia Vasilovici, Alina Vesa, Ștefan Cosgarea, Ioana Cosgarea, Rodica Șenilă, Simona Exp Ther Med Articles Patients with melanoma have an increased risk of having other neoplasms, and particularly other melanomas and non-melanoma skin cancers. The study aimed to describe multiple primary melanomas in a large medical university centre from Romania (Cluj-Napoca) from 2004 to 2020. Out of 699 patients with melanoma included in the study, 26 (3.71%) developed multiple tumours. The 26 patients developed a total of 59 melanomas, corresponding to a mean of 2.3 melanomas per patient. The site and histological subtype of the first and second melanomas were not consistent. The proportion of subsequent melanomas that were in situ (51.5%) or thin melanomas (<1 mm, 24.2%) was higher compared with first melanomas (7.7%, respectively 11.5%). The median and mean time to diagnosis was 2.75 months, respectively, 28.09 months. In total, 76.92% of second melanomas were detected within three years, but we were able to document a subsequent melanoma more than ten years after the first diagnosis. The study highlights the importance of follow-up in patients diagnosed with melanoma, not only in the first years after the primary diagnoses but for the entire life. D.A. Spandidos 2021-01 2020-11-26 /pmc/articles/PMC7725020/ /pubmed/33363599 http://dx.doi.org/10.3892/etm.2020.9520 Text en Copyright: © Ungureanu et al. This is an open access article distributed under the terms of the Creative Commons Attribution-NonCommercial-NoDerivs License (https://creativecommons.org/licenses/by-nc-nd/4.0/) , which permits use and distribution in any medium, provided the original work is properly cited, the use is non-commercial and no modifications or adaptations are made.
spellingShingle Articles
Ungureanu, Loredana
Zboraș, Iulia
Vasilovici, Alina
Vesa, Ștefan
Cosgarea, Ioana
Cosgarea, Rodica
Șenilă, Simona
Multiple primary melanomas: Our experience
title Multiple primary melanomas: Our experience
title_full Multiple primary melanomas: Our experience
title_fullStr Multiple primary melanomas: Our experience
title_full_unstemmed Multiple primary melanomas: Our experience
title_short Multiple primary melanomas: Our experience
title_sort multiple primary melanomas: our experience
topic Articles
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7725020/
https://www.ncbi.nlm.nih.gov/pubmed/33363599
http://dx.doi.org/10.3892/etm.2020.9520
work_keys_str_mv AT ungureanuloredana multipleprimarymelanomasourexperience
AT zborasiulia multipleprimarymelanomasourexperience
AT vasilovicialina multipleprimarymelanomasourexperience
AT vesastefan multipleprimarymelanomasourexperience
AT cosgareaioana multipleprimarymelanomasourexperience
AT cosgarearodica multipleprimarymelanomasourexperience
AT senilasimona multipleprimarymelanomasourexperience